Thermo Fisher Scientific Inc. Stock Drops 0.57% on Third Consecutive Day of Losses, Trading Volume Ranks 55th
1min read On April 25, 2025, Thermo Fisher Scientific Inc. (TMO) experienced a significant decline, with its stock price dropping by 0.57%, marking the third consecutive day of losses and a cumulative decrease of 2.41% over the past three days. The trading volume for the day was 11.42 billion, placing it at the 55th position in the daily market rankings.
Thermo Fisher Scientific Inc. has announced a substantial investment of $2 billion in its U.S. operations over the next four years. This investment is aimed at enhancing and expanding manufacturing capabilities, with $1.5 billion allocated to capital expenditures and $500 million dedicated to research and development focused on high-impact innovations. This strategic move is expected to bolster the U.S. healthcare supply chain and create a strong multiplier effect across the American economy.
The company's CEO, Marc N. Casper, emphasized that this investment will ensure the continued development and production of life-saving medicines and therapies in the U.S. for decades to come. Thermo Fisher currently operates 64 manufacturing facilities across 37 states and invests $1 billion annually in R&D within the U.S. This new investment is set to create high-paying jobs, increase manufacturing and lab services capacity, and further advance research and development efforts.
However, Thermo Fisher also acknowledged the potential impact of U.S.-China tariffs on its sales in China. The company estimates that these tariffs could reduce revenue by $400 million in 2025 and increase the cost of parts and subassemblies sourced from China. Despite efforts to mitigate these effects, the company expects a $375 million reduction in adjusted operating income compared to previous guidance.
